† These authors contributed equally to this work * Corresponding author. email: s.oliveira@uu.nl tel: +31(0)6 3410 3460 Supplementary Material: Figure S1 and S2. Figure S1 . EGFR mRNA expression differs between patient-derived organoid lines and is increased upon medium change to physiological EGF levels. (a) EGFR mRNA expression levels measured in organoid lines derived from different HNSCC patients. Expression is calculated relative to housekeeping gene GAPDH. Experiment was performed in technical triplicate. (b) culturing organoids under physiological EGF resulted in an increase in EGFR mRNA levels in 4/7 lines. EGFR expression is depicted as the ratio of EGFR in medium containing physiological EGF levels, versus EGFR expression in organoid cultured in high EGF medium. When this ratio is > 1, EGFR expression is increased in response to physiological EGF levels.
. Comparison of different PS carriers in EGFR-targeted PDT. Results of in vitro PDT screens performed with 7D12-PS, 7D12-G98-PS and cetuximab-PS in eight patient-derived HNSCC organoid lines and three matching wildtype organoid lines. Results of 7D12-PS are depicted in dashed lines and squared symbols, results of 7D12-9G8-PS in dotted lines and triangular symbols, and cetuximab-PS in solid lines and circular symbols. Color coding of the different samples is identical to that applied in the main figures. Supplementary Table S1 . details on targeted sequencing of organoids Used assay: Ion AmpliSeqTM Cancer Hotspot Panel v2+ Next Generation Sequencing Sequencing performed for research purposes in the UMC Utrecht *this assay only contains hotspot regions and does not provide information on the full sequence of the depicted genes **this assay has not officially been validated for detecting amplfications gene exons checked by oncopanel ABL1 4-7 AKT1
3,6 ALK 22-25 APC 14 ARAF 6 ATM 8, 9, 12, 17, 26, 34, 35, 36, 39, 50, 54, 55, 56, 59, 61 4, 13, 16 KDR 6, 7, 11, 19, 21, 26, 30 KIT 2, [9] [10] [11] [13] [14] [15] 17 , 4, 6, 7, 9, 13, 18, 20 PTEN 3, [5] [6] [7] [8] 13 RB1 4, 6, 10, 11, 14, 17 RET 10, 11, 13, 15, [8] [9] [10] [11] [12] 4, 5 SMO 3, 5, 6, 9, 11 SRC 14 STK11 1,4,6,8 TP53 2-10 VHL 1-3
